...
首页> 外文期刊>Neurology: Official Journal of the American Academy of Neurology >Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology.
【24h】

Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology.

机译:质量改进在神经学:河畔帕金森疾病质量措施:报告的质量计量和报告的委员会美国神经病学学会。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Measuring the quality of health care is a fundamental step toward improving health care and is increasingly used in pay-for-performance initiatives and maintenance of certification requirements. Measure development to date has focused on primary care and common conditions such as diabetes; thus, the number of measures that apply to neurologic care is limited. The American Academy of Neurology (AAN) identified the need for neurologists to develop measures of neurologic care and to establish a process to accomplish this. OBJECTIVE: To adapt and test the feasibility of a process for independent development by the AAN of measures for neurologic conditions for national measurement programs. METHODS: A process that has been used nationally for measure development was adapted for use by the AAN. Topics for measure development are chosen based upon national priorities, available evidence base from a systematic literature search, gaps in care, and the potential impact for quality improvement. A panel composed of subject matter and measure development methodology experts oversees the development of the measures. Recommendation statements and their corresponding level of evidence are reviewed and considered for development into draft candidate measures. The candidate measures are refined by the expert panel during a 30-day public comment period and by review by the American Medical Association for Current Procedural Terminology (CPT) II codes. All final AAN measures are approved by the AAN Board of Directors. RESULTS: Parkinson disease (PD) was chosen for measure development. A review of the medical literature identified 258 relevant recommendation statements. A 28-member panel approved 10 quality measures for PD that included full specifications and CPT II codes. CONCLUSION: The AAN has adapted a measure development process that is suitable for national measurement programs and has demonstrated its capability to independently develop quality measures.
机译:背景:测量质量的医疗保健是一项基本一步改善健康吗保健和越来越多的用于绩效工资计划和维护认证的要求。发展集中在初级保健和常见疾病如糖尿病;数量的措施,适用于神经护理是有限的。(长)神经学家需要识别神经系统保健和发展措施建立一个过程来完成。摘要目的:调整和测试的可行性长独立发展的过程措施为国家神经条件测量程序。是在全国范围内用于测量发展适用于长使用。基于国家发展选择优先级、可用的证据基础在保健方面系统性的文献检索,差距,质量改进的潜在影响。面板由主题和措施开发方法专家监督发展的措施。语句及其相应的水平证据审查和考虑发展到候选人措施草案。候选人措施完善的专家在30天的公共评论时间,面板通过回顾美国医学协会当前程序的术语(CPT)二码。所有河畔河畔最终批准的措施董事会。(PD)测量发展的选择。相关的医学文献确定了258推荐的语句。批准10 PD,包括质量措施完整的规格和CPT二码。河畔的已经适应了衡量开发过程适用于国家测量项目,并展示了其能力独立开发质量的措施。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号